NCT06413745

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2024-06-04Est. Completion: 2026-12-31

Enrollment target: 59 participants

Locations

Zhongshan Hospital，Fudan University, Shanghai, Shanghai Municipality, China

Other microbiome trials you might be interested in

A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ± Chemotherapy in Patients With Advanced Digestive System TumorsPhase 2Recruiting

Advanced Digestive System Tumor

This is a prospective, open-label, exploratory, phase II basket clinical trial designed to evaluate the efficacy and saf…

Wuhan, ChinaEst. completion Dec 31, 2030

View Trial →

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GenePhase 1Completed

HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene AmplificationHER2 Positive Gastric CancerSalivary Gland CancerSalivary Gland TumorSalivary Gland Carcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.